Whole Exome Sequencing Reveals Multiple Driver Events in Chronic Lymphocytic Leukemia Patients with Acquired Ibrutinib Resistance

被引：0
|
作者：
Underbayev, Chingiz [1 ]
Ahn, Inhye E. [1 ]
Harris, Hailey [1 ]
Vaughn, Lauren T. [1 ]
Pirooznia, Mehdi [2 ]
Xi, Liqiang [3 ]
Raffeld, Mark [3 ]
Herman, Sarah E. M. [1 ]
Wiestner, Adrian [1 ]
机构：
[1] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
[2] NHLBI, Bioinformat & Computat Biol Core, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA
[3] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127364
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Whole-exome sequencing identified mutational profile of a case with T-cell chronic lymphocytic leukemia
    Nozaki, Kenji
    Yokota, Takafumi
    Itotagawa, Eri
    Tsutsumi, Kazuhito
    Kusakabe, Shinsuke
    Morikawa, Yoichiro
    Fujita, Jiro
    Fukushima, Kentaro
    Maeda, Tetsuo
    Shibayama, Hirohiko
    Hosen, Naoki
    Kumanogo, Atsushi
    Kanakura, Yuzuru
    CLINICAL CASE REPORTS, 2020, 8 (11): : 2251 - 2254
  • [32] WHOLE EXOME SEQUENCING REVEALS CLONAL EVOLUTION PATTERNS AND DRIVER GENETIC ALTERATIONS OF RELAPSED PEDIATRIC ACUTE MYELOID LEUKEMIA
    Yoshida, K.
    Shiba, N.
    Shimada, A.
    Terui, K.
    Kato, M.
    Shiraishi, Y.
    Okuno, Y.
    Nagata, Y.
    Kon, A.
    Kataoka, K.
    Yoshizato, T.
    Shiozawa, Y.
    Matsunawa, M.
    Chiba, K.
    Tanaka, H.
    Sanada, M.
    Miyano, S.
    Ito, E.
    Hayashi, Y.
    Ogawa, S.
    HAEMATOLOGICA, 2014, 99 : 16 - 17
  • [33] Mechanisms of ibrutinib resistance in chronic lymphocytic leukemia and alternative treatment strategies
    Lama, Tsering Gyalpo
    Kyung, Daniel
    O'Brien, Susan
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (08) : 871 - 883
  • [34] Ibrutinib in Chronic Lymphocytic Leukemia: Clinical Applications, Drug Resistance, and Prospects
    Zhou, Hong
    Hu, Pan
    Yan, Xiyue
    Zhang, Yaping
    Shi, Wenyu
    ONCOTARGETS AND THERAPY, 2020, 13 : 4877 - 4892
  • [35] Combined Ibrutinib and Venetoclax for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Awan, Farrukh T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 13 - 14
  • [36] Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib
    Jain, Preetesh
    Keating, Michael
    Wierda, William
    Estrov, Zeev
    Ferrajoli, Alessandra
    Jain, Nitin
    George, Binsah
    James, Danelle
    Kantarjian, Hagop
    Burger, Jan
    O'Brien, Susan
    BLOOD, 2015, 125 (13) : 2062 - 2067
  • [37] Efficacy and Safety of Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia
    Cao, Zhijian
    Ma, Jun
    BLOOD, 2019, 134
  • [38] Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia
    Niemann, Carsten U.
    Levin, Mark-David
    Dubois, Julie
    Kersting, Sabina
    Enggaard, Lisbeth
    Veldhuis, Gerrit J.
    Mous, Rogier
    Mellink, Clemens H. M.
    Dobber, Johan A.
    Poulsen, Christian B.
    Frederiksen, Henrik
    Janssens, Ann
    Schjodt, Ida
    Dompeling, Ellen C.
    Ranti, Juha
    Mattsson, Mattias
    Bellido, Mar
    Tran, Hoa T. T.
    Nasserinejad, Kazem
    Kater, Arnon P.
    BLOOD, 2021, 137 (08) : 1117 - 1120
  • [39] Pharmacokinetics (PK) of ibrutinib in patients with chronic lymphocytic leukemia (CLL)
    Sukbuntherng, Juthamas
    Jejurkar, Purvi
    Chan, Stephen
    Tran, Anh L.
    Moussa, Davina
    James, Danelle Frances
    Loury, David
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Pharmacogenetic Study of Ibrutinib Toxicity in Chronic Lymphocytic Leukemia Patients
    Labrador, Jorge
    Victoria Cuevas, Maria
    Alonso-Madrigal, Cristina
    Zubiaur, Pablo
    Azibeiro, Raul
    Cuevas, Beatriz
    Alvarez, Rodolfo
    Javier Diaz-Galvez, Francisco
    Jose Gonzalez-Lopez, Tomas
    Alcaraz, Raquel
    Paola Mejia-Abril, Gina
    Loscertales, Javier
    Abad, Francisco
    Saiz-Rodriguez, Miriam
    BLOOD, 2022, 140 : 12405 - 12406
12345